» Articles » PMID: 2940518

Pharmacokinetics of Ciprofloxacin in Elderly Subjects

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 1986 Mar 1
PMID 2940518
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics of single-dose oral ciprofloxacin 500 mg was ascertained in 12 elderly and 12 young subjects. Mean age of the elderly volunteers was 75.4 years and the mean measured creatinine clearance in this group was 40.7 ml/min. Serum and saliva were collected in serial order for 24 hours (elderly) and 10 hours (young), and assayed for ciprofloxacin by high-performance liquid chromatography. The geriatric subjects had higher serum levels throughout the sampling period, with a peak level of 3.24 +/- 0.79 versus 2.26 +/- 0.75 micrograms/ml for the younger group (p less than 0.005; one-way analysis of variance). A twofold increase in the ciprofloxacin half-life may be partly explained by a decrease in the glomerular filtration rate, as shown by slower ciprofloxacin renal clearance (152.4 +/- 54.2 vs 395.6 +/- 139.0 for elderly and young subjects respectively; p less than 0.001). We concluded that in elderly patients, ciprofloxacin should be administered at an interval not less than every 12 hours to prevent accumulation and eventually toxicity.

Citing Articles

A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.

Schlender J, Teutonico D, Coboeken K, Schnizler K, Eissing T, Willmann S Clin Pharmacokinet. 2018; 57(12):1613-1634.

PMID: 29737457 PMC: 6267540. DOI: 10.1007/s40262-018-0661-6.


Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.

Navid A, Ng D, Wong S, Lightstone F CPT Pharmacometrics Syst Pharmacol. 2016; 5(2):74-81.

PMID: 26933518 PMC: 4761233. DOI: 10.1002/psp4.12061.


Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.

OBrien D, Friedman N, Cowan R, Pollard J, McDonald A, Callan P PLoS Negl Trop Dis. 2015; 9(12):e0004253.

PMID: 26630648 PMC: 4667883. DOI: 10.1371/journal.pntd.0004253.


A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Kiang T, Ensom M Clin Pharmacokinet. 2015; 55(3):313-58.

PMID: 26346776 DOI: 10.1007/s40262-015-0321-z.


Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients.

Sanchez Navarro M, Coloma Milano C, Zarzuelo Castaneda A, Sayalero Marinero M Clin Pharmacokinet. 2002; 41(14):1213-20.

PMID: 12405867 DOI: 10.2165/00003088-200241140-00005.